Microbot Medical Inc reports results for the quarter ended June 30 - Earnings Summary
Microbot Medical Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Microbot Medical® Enters Into An Agreement To Expand Access For America’S Veteran And Military Patient Populations
Microbot Medical rises as U.S. federal supply deal expands reach of robotic surgical device
Brief: Microbot Medical Recorded Revenue During Its Quarter Ended March 31, Benefiting From Limited Market Release Of Liberty System
Brief: Microbot Medical®’S Liberty® Endovascular Robotic System Is Now Adopted By Multiple Accounts Across Key Territories Including Two Access-Pvi Pivotal Clinical Trial Sites
Brief: Microbot Medical Continues Its 2025 Momentum Announces Key 2026 Milestones
Brief: Microbot Medical Launches Limited Market Release Of Liberty Endovascular Robotic System In US
Brief: Microbot Medical Inc Files For Offering Of Up To 14.7 Million Shares Of Common Stock By The Selling Stockholders - SEC Filing
Brief: Microbot Medical Receives First Patent In Japan For Liberty System - SEC Filing
Brief: Microbot Medical Exercises Preferred Investment Options For Up To $92.2 Million In Gross Proceeds
Brief: Microbot Medical® Receives FDA 510(K) Clearance For Its Liberty® Endovascular Robotic System
Microbot Medical Inc reports results for the quarter ended June 30 - Earnings Summary
Microbot Medical Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Microbot Medical® Receives Non-Dilutive Grant To Enhance Operational Capabilities
Microbot Medical Inc reports results for the quarter ended March 31 - Earnings Summary
Microbot Medical Inc expected to post a loss of 13 cents a share - Earnings Preview
Microbot Medical Inc expected to post a loss of 13 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Walmart, Ford Motor, Starbucks